[
  {
    "ts": "2026-01-07T09:09:23+00:00",
    "headline": "Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum",
    "summary": "Context for Gilead Sciences stock today Gilead Sciences (GILD) is in focus for investors after recent share price moves, with the stock showing mixed returns over the past week, month, and past 3 months, and a flat year to date performance. See our latest analysis for Gilead Sciences. At a share price of $121.36, Gilead Sciences has seen a 2.59% 1 day share price return alongside a 37.65% 1 year total shareholder return, which indicates recent momentum following a softer move year to date. If...",
    "url": "https://finance.yahoo.com/news/assessing-gilead-sciences-gild-valuation-090923779.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "126dee76-bad5-3163-b183-b1fa90f9b78c",
      "content": {
        "id": "126dee76-bad5-3163-b183-b1fa90f9b78c",
        "contentType": "STORY",
        "title": "Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum",
        "description": "",
        "summary": "Context for Gilead Sciences stock today Gilead Sciences (GILD) is in focus for investors after recent share price moves, with the stock showing mixed returns over the past week, month, and past 3 months, and a flat year to date performance. See our latest analysis for Gilead Sciences. At a share price of $121.36, Gilead Sciences has seen a 2.59% 1 day share price return alongside a 37.65% 1 year total shareholder return, which indicates recent momentum following a softer move year to date. If...",
        "pubDate": "2026-01-07T09:09:23Z",
        "displayTime": "2026-01-07T09:09:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HAEiJmFsYXJTRBPxnneP6w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hXB9F2qU7k4qk3_k1DQd9A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/assessing-gilead-sciences-gild-valuation-090923779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/assessing-gilead-sciences-gild-valuation-090923779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]